Your browser doesn't support javascript.
loading
Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy.
Bian, Yicong; Huang, Minzhou; Ma, Sheng; Liu, Linsheng; Xia, Fan; Chen, Zhiyao; Yu, Di; Huang, Chenrong; Miao, Liyan.
Afiliação
  • Bian Y; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Huang M; College of Pharmaceutical Science, Soochow University, Suzhou, Jiangsu 215000, China.
  • Ma S; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Liu L; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Xia F; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Chen Z; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Yu D; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Huang C; College of Pharmaceutical Science, Soochow University, Suzhou, Jiangsu 215000, China.
  • Miao L; Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Chin Med J (Engl) ; 135(11): 1383-1385, 2022 06 05.
Article em En | MEDLINE | ID: mdl-35838415

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China